COVID-19: Vaccines and Therapeutics

Feb 10, 2021
The Food and Drug Administration authorized administering the monoclonal antibodies bamlanivimab and etesevimab together to treat patients 12 and older with mild-to-moderate COVID-19 who are at high risk for progressing to severe disease but not hospitalized or on oxygen therapy.
Feb 9, 2021
An estimated 68% of U.S. adults intended to receive a COVID-19 vaccine when surveyed by the Centers for Disease Control and Prevention in December, up from 61.9% in September.
Feb 8, 2021
Congress is discussing another COVID-19 relief package, one that would use its reconciliation process to approve legislation that could spur the nation’s health and economic recoveries from the ongoing pandemic. The following resources will aid AHA members’ efforts to advocate on behalf of…
Feb 8, 2021
The Food and Drug Administration revised and reissued its emergency use authorization for COVID-19 convalescent plasma to treat hospitalized patients with COVID-19.
Feb 5, 2021
The Food and Drug Administration cautioned health care providers against using compounded remdesivir drug products due to the potential for patient exposure to substandard or adulterated products.
Feb 5, 2021
The Food and Drug Administration announced that its Vaccines and Related Biological Products Advisory Committee will convene Feb. 26 to discuss the emergency use authorization application by Johnson & Johnson and Janssen Biotech, Inc. for its investigational single-dose COVID-19 vaccine candidate.
Feb 4, 2021
AHA is partnering with the American Medical Association and the American Nurses Association to urge the public to get vaccinated against COVID-19 when their opportunity arises.
Feb 4, 2021
Together, the American Hospital Association (AHA), American Medical Association (AMA), and American Nurses Association (ANA) released a public service announcement (PSA) today urging the American public to get the COVID-19 vaccination when it is their turn.
Feb 3, 2021
Academies of Sciences, Engineering, and Medicine released guidance on communication strategies to combat mistrust and build confidence in COVID-19 vaccines based on research on decision making, changing beliefs/attitudes, and reaching and engaging diverse audiences.
Feb 2, 2021
The House Energy and Commerce Subcommittee on Oversight and Investigations held a hearing to examine the distribution and administration of COVID-19 vaccines. Testifying at the hearing were public health officials from Illinois, Michigan, West Virginia, Louisiana and Colorado.